Bank Of America Corp Lineage Cell Therapeutics, Inc. Transaction History

Bank Of America Corp

  • $1.43 Trillion
  • Q3 2025

A detailed history of Bank Of America Corp transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 233,436 shares of LCTX stock, worth $443,528. This represents 0.0% of its overall portfolio holdings.

Number of Shares
233,436
Previous 103,312 125.95%
Holding current value
$443,528
Previous $94,000 328.72%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$0.87 - $1.79 $113,207 - $232,921
130,124 Added 125.95%
233,436 $403,000
Q2 2025

Aug 14, 2025
SELL
$0.39 - $1.13 $22,487 - $65,156
-57,661 Reduced 35.82%
103,312 $94,000
Q1 2025

May 15, 2025
BUY
$0.45 - $0.72 $55,286 - $88,457
122,858 Added 322.34%
160,973 $72,000
Q4 2024

Feb 14, 2025
SELL
$0.5 - $0.95 $667,153 - $1.27 Million
-1,334,307 Reduced 97.22%
38,115 $19,000
Q3 2024

Nov 14, 2024
BUY
$0.8 - $1.12 $9,197 - $12,876
11,497 Added 0.84%
1,372,422 $1.25 Million
Q2 2024

Aug 14, 2024
BUY
$0.89 - $1.47 $44,183 - $72,976
49,644 Added 3.79%
1,360,925 $1.36 Million
Q1 2024

May 15, 2024
BUY
$0.86 - $1.48 $1.11 Million - $1.91 Million
1,287,428 Added 5397.34%
1,311,281 $1.94 Million
Q4 2023

Feb 14, 2024
SELL
$0.91 - $1.35 $44,004 - $65,281
-48,357 Reduced 66.97%
23,853 $25,000
Q2 2023

Aug 14, 2023
SELL
$1.26 - $1.53 $1.73 Million - $2.1 Million
-1,371,569 Reduced 95.0%
72,210 $101,000
Q1 2023

May 12, 2023
BUY
$1.2 - $1.53 $1.73 Million - $2.21 Million
1,442,750 Added 140208.94%
1,443,779 $2.17 Million
Q4 2022

Feb 10, 2023
BUY
$1.02 - $1.5 $22 - $33
22 Added 2.18%
1,029 $1,000
Q3 2022

Nov 14, 2022
SELL
$1.13 - $1.77 $11,292 - $17,687
-9,993 Reduced 90.85%
1,007 $1,000
Q1 2022

May 16, 2022
SELL
$1.21 - $2.48 $29,334 - $60,122
-24,243 Reduced 68.79%
11,000 $17,000
Q4 2021

Feb 08, 2022
BUY
$1.84 - $2.68 $43,517 - $63,384
23,651 Added 204.03%
35,243 $86,000
Q3 2021

Nov 15, 2021
SELL
$2.26 - $2.86 $13,191 - $16,693
-5,837 Reduced 33.49%
11,592 $29,000
Q2 2021

Sep 13, 2021
BUY
$2.17 - $3.0 $37,820 - $52,287
17,429 New
17,429 $49,000

Others Institutions Holding LCTX

# of Institutions
128
Shares Held
96M
Call Options Held
251K
Put Options Held
50K
View Full List

About Lineage Cell Therapeutics, Inc.

LCTX Quotes by TradingView
  • Ticker LCTX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 169,755,008
  • Market Cap $323M
  • Description
  • Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...
More about LCTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email